GDF15 and fibrosis: Overall, the subjects with initial advanced fibrosis exhibited considerably higher basal GDF15 serum levels (688 vs. 339 pg/mL; p < 0.001) and also experienced a transient GDF15 increase during the first 3 months of weight loss therapy (Figure 3B).